rifampin and Alopecia

rifampin has been researched along with Alopecia* in 3 studies

Other Studies

3 other study(ies) available for rifampin and Alopecia

ArticleYear
A young man with livid facial nodules and a loss of eyebrows.
    The Lancet. Infectious diseases, 2013, Volume: 13, Issue:3

    Topics: Adult; Alopecia; Clofazimine; Dapsone; Eyebrows; Facial Dermatoses; Humans; Leprostatic Agents; Leprosy, Multibacillary; Male; Rifampin

2013
Isonicotinic acid hydrazide induced anagen effluvium and associated lichenoid eruption.
    The Journal of dermatology, 2001, Volume: 28, Issue:12

    A 32 year-old woman developed generalised lichenoid eruptions on her body followed by diffuse loss of scalp hair of the anagen effluvium type. She was receiving several anti-tubercular drugs, including rifampicin, isonicotinic acid hydrazide (INH), pyrazinamide, and ethambutol, for abdominal tuberculosis. INH, which is a leading cause of drug eruptions in the above group of drugs was withdrawn. However, the other antitubercular drugs were continued along with 40 mg of prednisolone in a single daily morning dose. The latter was discontinued slowly over a period of 10 weeks. There was complete recovery of hair loss and the regrowth started after 12 weeks of alopecia. Such anagen effluvium with lichenoid eruption following INH therapy has not been observed previously. The complete recovery from anagen effluvium is difficult to explain, but it could have been because of the early initiation of corticosteroid.

    Topics: Adult; Alopecia; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Lichenoid Eruptions; Pyrazinamide; Rifampin; Scalp Dermatoses; Tuberculosis, Gastrointestinal

2001
Folliculitis decalvans--response to rifampin.
    Cutis, 1988, Volume: 42, Issue:6

    Folliculitis decalvans is a rare follicular inflammatory disease of the scalp. It is characterized by initial perifollicular inflammatory changes followed by peripheral extension and eventual circumscribed patches of cicatricial alopecia. The disease is known for its resistance to treatment, resulting in an unfavorable prognosis. The cause of the disease is unknown, although a bacterial etiology is postulated. We report a classic case that was temporized with various antibiotics and only subsequently resolved after ten weeks of therapy with rifampin. The patient has remained free of disease for more than one year. We present a brief review of the cicatricial alopecias and discuss rifampin therapy for this condition.

    Topics: Adult; Alopecia; Cicatrix; Female; Folliculitis; Humans; Rifampin

1988